Hepatology International

Công bố khoa học tiêu biểu

* Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp:  
Safety and tolerance of sorafenib in Japanese patients with advanced hepatocellular carcinoma
Hepatology International - - 2011
Satoshi Ogasawara, Fumihiko Kanai, Shuntaro Obi, Shinpei Sato, Taketo Yamaguchi, Ryosaku Azemoto, Hideaki Mizumoto, Youhei Koushima, Naoki Morimoto, Nobuto Hirata, Takeshi Toriyabe, Yusuke Shinozaki, Yoshihiko Ooka, Rintaro Mikata, Tetsuhiro Chiba, Shinichiro Okabe, Fumio Imazeki, Masaharu Yoshikawa, Osamu Yokosuka
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update
Hepatology International - Tập 13 Số 4 - Trang 353-390 - 2019
Shiv Kumar Sarin, Ashok Choudhury, Manoj Kumar, Rakhi Maiwall, Mamun Al Mahtab, Salimur Rahman, Sanjiv Saigal, Neeraj Saraf, Arvinder S. Soin, Harshad Devarbhavi, Dong Joon Kim, Shankar Prinja, Ajay Duseja, Sunil Taneja, C. E. Eapen, Ashish Goel, Qin Ning, Tao Chen, Ke Ma, Zhongping Duan, Yú Chen, Sombat Treeprasertsuk, Saeed Hamid, Amna S. Butt, Wasim Jafri, Akash Shukla, Vivek A. Saraswat, Soek Siam Tan, Ajit Sood, Vandana Midha, Omesh Goyal, Hasmik Ghazinyan, Anil Arora, Jinhua Hu, Manoj Kumar Sahu, Padaki Nagaraja Rao, Guan Huei Lee, Seng Gee Lim, Laurentius A. Lesmana, Cosmas Rinaldi Adithya Lesmana, Samir Shah, V. G. Mohan Prasad, Diana A. Payawal, Zaigham Abbas, A. Kadir Dokmeci, Jose D. Sollano, Gian Carpio, Ananta Shresta, George Lau, Md. Fazal Karim, Gamal Shiha, Rino Alvani Gani, Kemal Fariz Kalista, Man‐Fung Yuen, Bikrant Bihari Lal, Rajeev Khanna, Vikrant Sood, Viniyendra Pamecha, Ankur Jindal, V. Rajan, Vinod Arora, Osamu Yokosuka, Madunil Anuk Niriella, Hai Li, Xiaolong Qi, Atsushi Tanaka, Satoshi Mochida, Dominic Ray Chaudhuri, Edward Gane, Khin Maung Win, Wei Ting Chen, M Rela, Dharmesh Kapoor, Amit Rastogi, Pratibha Kale, Archana Rastogi, Chhagan Bihari Sharma, Meenu Bajpai, Virender Singh, Madhumita Premkumar, Sudhir Maharashi, A. Olithselvan, Cyriac Abby Philips, Anshu Srivastava, Surender Kumar Yachha, Zeeshan Ahmad Wani, Thapa Br, Anoop Saraya, Raju Sharma, Ashish Kumar, Manav Wadhawan, Subhash Gupta, Kaushal Madan, Puja Sakhuja, Vivek Vij, Barjesh Chander Sharma, Hitendra Garg, Vishal Garg, Chetan Kalal, Lovkesh Anand, Tanmay Vyas, Rajendra Prasad Mathur, Guresh Kumar, Priyanka Jain, Samba Siva Rao Pasupuleti, Yogesh Chawla, Abhijit Chowdhury, Shahinul Alam, Do Seon Song, Jin Mo Yang, Eileen L. Yoon
Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis
Hepatology International - - 2019
Natasha Kamal, Christopher Koh, Niharika Samala, Robert J. Fontana, Andrew Stolz, Francisco Durazo, Paul H. Hayashi, Elizabeth Phillips, Tongrong Wang, Jay H. Hoofnagle
l-Asparaginase is a bacterial enzyme used in the treatment of acute lymphoblastic leukemia. In the ongoing U.S. Drug-Induced Liver Injury Network (DILIN) prospective study, standard and pegylated asparaginase were the most frequent cause of liver injury with jaundice among anti-cancer agents (8 of 40: 20%). The unique features of this hepatotoxicity are described. Eight cases from 5 DILIN centers ...... hiện toàn bộ
A randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatment
Hepatology International - Tập 10 - Trang 799-806 - 2016
Yuko Takami, Susumu Eguchi, Masaki Tateishi, Tomoki Ryu, Kazuhiro Mikagi, Yoshiyuki Wada, Hideki Saitsu
Because the recurrence rate of hepatocellular carcinoma (HCC) is high, even after curative treatments such as hepatic resection and microwave ablation, chemopreventive agents that can effectively suppress HCC recurrence are required. Cyclooxygenase-2 (Cox-2) was recently found to be overexpressed in HCC. Therefore, Cox-2 inhibitors may offer a chemopreventive therapy for HCC. This randomised contr...... hiện toàn bộ
MAFLD as part of systemic metabolic dysregulation
Hepatology International -
Jingbo Zhao, Lu Liu, Yingying Cao, Xin Gao, Giovanni Targher, Christopher D. Byrne, Dan‐Qin Sun, Ming‐Hua Zheng
Immune therapy for hepatocellular carcinoma
Hepatology International - - 2014
Yaron Ilan
Prognosis prediction or treatment allocation?
Hepatology International - - 2021
Ryosuke Tateishi
Abstracts
Hepatology International - - 2020
Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B
Hepatology International - Tập 6 - Trang 696-706 - 2011
Sang-Hoon Ahn, Young-Oh Kweon, Seung-Woon Paik, Joo-Hyun Sohn, Kwan-Sik Lee, Dong Joon Kim, Teerha Piratvisuth, Man Fung Yuen, Anuchit Chutaputti, You-Chen Chao, Aldo Trylesinski, Claudio Avila
Lamivudine (LAM) resistance is common on lamivudine monotherapy for chronic hepatitis B. This study examined the safety and efficacy of telbivudine (LDT) given with adefovir (ADV) versus ADV monotherapy in patients with chronic, lamivudine-resistant HBV infection. An open-label, 96 week study with planned recruitment of 150 HBeAg-positive, lamivudine-experienced Asian patients with a confirmed YMD...... hiện toàn bộ
Ethnicity predicts metabolic syndrome after liver transplant
Hepatology International - Tập 7 - Trang 741-748 - 2012
Claudia A. Couto, Claudio L. Gelape, Iliana B. Doycheva, Jonathan K. Kish, Paul Martin, Cynthia Levy
Post-transplant metabolic syndrome (PTMS) is associated with important causes of morbidity and mortality in solid organ transplant recipients. Our aim was to investigate predictors of PTMS in liver transplant (LT) recipients. We randomly selected 343 adults (>18 years of age) from a large cohort of 1,262 ethnically diverse patients who received LTs during 2000–2010. Of 343 patients included, 68.2 ...... hiện toàn bộ
Tổng số: 1,137   
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10